Clinical Trial Detail
| NCT ID | NCT04429542 |
| Title | Study of Safety and Tolerability of BCA101 Alone and in Combination With Pembrolizumab in Patients With EGFR-driven Advanced Solid Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | Bicara Therapeutics |
| Indications |
anal canal squamous cell carcinoma thyroid gland anaplastic carcinoma head and neck squamous cell carcinoma |
| Therapies | |
| Age Groups: | adult senior |
CKB BOOST